Invion Ltd has released a press release.
Pre-clinical research agreement with Peter MacCallum CC
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Invion
- Appendix 4C - September 2019 quarter
- Appendix 4E and Financial Report for year ended 30 June 2019
- COO Craig Newton to transition to Invion CEO
- Appendix 4C - June quarter
- Animal studies show IVX-P02 potential in metastatic cancers
Later from Invion
- Additional Information to Prior Announcement
- Appendix 4C - December 2019 quarter
- Invion signs R&D Services Agreement with Pavay Biotech
- App 4D and Financial Report for half year to 31 Dec 2019
- Appendix 4C - March 2020 quarter
Follow Invion into a list and get an email when it puts out news.
Follow Invion